Skip to content

Net margin at other companies

Eli Lilly logo
Eli LillyLLY
35%+12.3pp
AbbVie logo
AbbVieABBV
5.8%-1.5pp
Establishment Labs logo
Establishment LabsESTA
-19.1%-7.4pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
-1.9%-0.9pp

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Calculated from AirSculpt Technologies, Inc.’s reported figures.

Based on trailing twelve months.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed November 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s net margin?
AirSculpt Technologies, Inc. (AIRS) reported net margin of -11.3% in Q3 2025.
How has AirSculpt Technologies, Inc.'s net margin changed year-over-year?
AirSculpt Technologies, Inc.'s net margin decreased by 181.6% year-over-year, from -4% to -11.3%.
What is the long-term trend for AirSculpt Technologies, Inc.'s net margin?
Over 4 years (2020 to 2024), AirSculpt Technologies, Inc.'s net margin has grown at a -22.1% compound annual growth rate (CAGR), from 12.1% to -4.4%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.